Chroma Medicine Highlights Data Demonstrating Durable Multiplex Epigenetic Editing to Enhance Allogeneic CAR T at 65th ASH Annual Meeting
Multiplex allogeneic epigenetic edits demonstrate elimination of graft-versus-host disease and resistance of CD8+T, CD4+T, and NK cell responses, while preserving genomic integrity Chroma’s allogeneic approach has the potential to drive greater persistence of a CAR T relative to current allog
Aqua Bridge Group and Enertech launch Aqua Bridge Kuwait at COP28, in boost for local food systems and fisheries
Joint venture poised to decarbonize Kuwait’s food supply chains, reinforce resource resilience of aquaculture and fisheries sectors DUBAI, UAE, Dec. 10, 2023 /PRNewswire/ — Aqua Bridge Group, a global leader in aquaculture development, and Enertech, the Kuwait-based innovator, investor
Studies Highlight Both Novel Treatments and Enduring Value of Older Approaches
Findings suggest “less is more” and “tried and true” may benefit select patients SAN DIEGO, Dec. 10, 2023 /PRNewswire/ — Research findings being presented at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition highlight new treatment approaches
Statement by Minister St-Onge on Human Rights Day
On Human Rights Day, let’s work together to promote freedom, equality and justice for every person. OTTAWA, ON, Dec. 10, 2023 /CNW/ – Today, on Human Rights Day, the Honourable Pascale St-Onge, Minister of Canadian Heritage made the following statement. “The Government of Canada
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SolarEdge Technologies, Inc. – SEDG
NEW YORK, Dec. 10, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of SolarEdge Technologies, Inc. (“SolarEdge” or the “Company”) (NASDAQ: SEDG). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com
Freedom, Equality and Justice Lead to Peace
Human Rights Day Statement by Education Cannot Wait Executive Director Yasmine Sherif NEW YORK, Dec. 10, 2023 /PRNewswire/ — Today we mark a milestone in history: the 75th anniversary of the Universal Declaration of Human Rights. As people around the world commemorate Human Rights Day, we must
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capstone Green Energy Corporation – CGRNQ
NEW YORK, Dec. 10, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Capstone Green Energy Corporation (“Capstone” or the “Company”) (OTC: CGRNQ). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On InMode Ltd.- INMD
NEW YORK, Dec. 10, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of InMode Ltd. (“InMode” or the “Company”) (NASDAQ: INMD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. T
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DMC Global Inc. – BOOM
NEW YORK, Dec. 10, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of DMC Global Inc. (“DMC” or the “Company”) (NASDAQ: BOOM). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-652
ILLUMINA DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $100,000 investing in Illumina securities between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional